Oncoclinicas do Brasil (ONCO3) — Capital Reinvestment Ratio
Oncoclinicas do Brasil (ONCO3) has a Capital Reinvestment Ratio of 0.35x as of September 2025, meaning it reinvests 0% of its operating cash flow (R$151.75 Million) in capital expenditures (R$52.99 Million). Check Oncoclinicas do Brasil tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Oncoclinicas do Brasil Capital Reinvestment Ratio (2013–2020)
This chart tracks Oncoclinicas do Brasil's Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see how efficiently does Oncoclinicas do Brasil generate cash.
Annual Capital Reinvestment Ratio for Oncoclinicas do Brasil (2013–2020)
Year-by-year Capital Reinvestment Ratio for Oncoclinicas do Brasil from 2013 to 2020. See Oncoclinicas do Brasil (ONCO3) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (BRL) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 2.10x | R$97.56 Million | R$204.80 Million | ▲ +7.1% |
| 2019 | 1.96x | R$97.08 Million | R$190.19 Million | ▼ -68.1% |
| 2018 | 6.14x | R$38.86 Million | R$238.45 Million | ▲ +2296.1% |
| 2017 | 0.26x | R$135.26 Million | R$34.64 Million | ▼ -83.7% |
| 2014 | 1.57x | R$9.29 Million | R$14.57 Million | ▼ -30.5% |
| 2013 | 2.26x | R$7.34 Million | R$16.58 Million | — |